ApiJect Systems
ApiJect Systems Corp., a CT-based medical firm, produces single-use prefilled injectors for pharmaceuticals and biotech.
Founded
2018ApiJect Systems Corp., a CT-based medical firm, produces single-use prefilled injectors for pharmaceuticals and biotech.
ApiJect Systems Corporation, founded in 2018 by Marc Koska and based in Stamford, Connecticut, is a medical organization specializing in the production of pre-filled single-use plastic injectors. The company's core mission is to enhance the delivery of injectable medicines by providing scalable, cost-efficient drug delivery systems. ApiJect collaborates with pharmaceutical and biotech companies to fill their injectable drug products into single-dose prefilled injectors, leveraging Blow-Fill-Seal (BFS) aseptic drug packaging technology.
Notable figures associated with ApiJect include its founder Marc Koska, an innovator in medical device technology. The company has garnered attention for its capacity to manufacture pre-filled COVID-19 vaccine syringes by the end of 2020. ApiJect's key achievements include establishing a proof-of-concept at its Orlando Technology Development Center and advancing the integration of BFS technology in drug delivery. Overall, ApiJect has significantly impacted the pharmaceutical industry by improving the efficiency and safety of injectable drug administration.
Companies similar to ApiJect Systems include Pharmajet, American Injectables, Enable Injections and Portal Instruments.
ApiJect Systems was founded in 2018.
ApiJect Systems' headquarters is located in Stamford, CT, US.
ApiJect Systems' most recent funding round was for $111M (USD) in May 2022.
As of May 18, 2022, ApiJect Systems has disclosed funding of $111M (USD). Undisclosed round amounts are excluded.
ApiJect Systems has 89 employees as of Feb 4, 2024.
Portal Instruments
